Why Is Breast Imaging Suspicious After a Benign Biopsy?

When your biopsy pathology report shows a benign result like fibrosis (thickened, scar-like connective tissue), but your mammogram or ultrasound was highly suspicious, your diagnostic journey is not yet complete. This mismatch is called a discordant benign result. It means the benign tissue found in the biopsy does not logically explain the abnormal spot seen on your imaging ^[1].

This can be stressful because the available results do not yet provide a clear explanation. However, a discordant result is not a cancer diagnosis. It simply serves as a critical safety check—a signal that the biopsy might have missed the true cause of the suspicious image, requiring your care team to investigate further through expert review and often a repeat procedure ^[1][2].

What Radiologic-Pathologic Discordance Means (And Doesn’t Mean)

After an image-guided biopsy, the breast radiologist and pathologist must compare the pathology report (what the cells look like under a microscope) with the imaging report (what the spot looked like on the scan) ^[3].

• Concordant: The findings align. It is important to know that uncomplicated fibrosis can be a concordant, fully acceptable explanation for certain imaging findings ^[1]. If the findings match, the diagnosis is considered complete.
• Discordant: The findings do not logically match ^[4]. For example, if your mammogram showed a highly suspicious mass, but the biopsy only pulled out normal breast tissue or simple fibrosis, the radiologist will flag this as a mismatch ^[1][5].

Discordance usually happens because of sampling limitations. The biopsy needle may have grazed the edge of the suspicious area, passed right through it, or pulled out neighboring fibrous tissue instead of the primary target ^[6]. Factors like the size of the needle, the biopsy method, and how clearly the spot can be seen on imaging all impact this risk ^[6][7]. Often, radiologists will use post-biopsy imaging to check if a tiny metallic marker clip was successfully placed exactly at the target, which helps determine if the needle reached the right spot ^[5].

Why Further Action is Necessary

While it is a relief to hear the word “benign,” a discordant result should not be treated as a final all-clear until the imaging and pathology are officially reconciled ^[1].

Studies show that discordant benign lesions carry a clinically meaningful risk that malignancy will be found on repeat sampling or excision ^[1]. In certain representative studies of discordant biopsies, between 20% and 40% of cases were ultimately found to contain cancer when the area was fully evaluated, and this risk can be even higher depending on how suspicious the initial scan was (e.g., highly suspicious BI-RADS 5 lesions) ^[1][8]. However, these are study averages, not your personal risk—many lesions do remain benign after adequate repeat sampling.

Because of the risk of a missed diagnosis, medical guidelines recommend timely diagnostic resolution rather than routinely waiting six months to see if the spot grows ^[1].

How Your Team Resolves the Mismatch

When you have a discordant result, your medical team will follow a structured process to ensure accurate diagnosis.

1. Radiology-Pathology Correlation Review

The foundational step is a direct review by the breast radiologist and pathologist to re-evaluate the images, biopsy targeting, clip position, and tissue slides ^[9]. In complex cases, this may happen at a formal multidisciplinary conference (often called a “tumor board”) where surgeons also provide input ^[10]. Sometimes, expert review can reclassify a discordant result as concordant, preventing unnecessary surgery ^[10].

2. Repeat Image-Guided Biopsy

If the team agrees the initial biopsy did not capture the target, they may recommend a second needle biopsy. Often, this is a vacuum-assisted biopsy (VAB), which uses suction to pull larger volumes of tissue, or a biopsy guided by a different imaging method like MRI ^[11].

• What to expect: Like your first biopsy, this is done under local anesthesia. Because it takes more tissue, you may experience slightly more bruising, bleeding, or soreness afterward.
• Keep in mind: While a repeat biopsy provides more tissue, it is not a guarantee. If the second biopsy is still discordant, further steps are needed ^[12].

3. Diagnostic Excisional Biopsy (Surgery)

If a repeat needle biopsy is not technically safe or possible, or if discordance persists after a second attempt, the team will recommend a surgical excisional biopsy ^[1][13].

• What to expect: This is a localized surgery to remove the suspicious area so the pathologist can examine it in its entirety ^[14]. It is a diagnostic procedure, not necessarily a cancer treatment, though it requires anesthesia and will result in a small scar and a longer recovery time than a needle biopsy.

Taking Charge of Your Care

• Do not wait for symptoms: You should not wait for new symptoms (like a lump or discharge) to complete your recommended follow-up. Symptoms—or the absence of them—do not determine whether the biopsy was adequate ^[15].
• Confirm the timeline: Contact your breast-imaging or referring team promptly to confirm the plan. The exact timing depends on the imaging findings and local scheduling; your clinician can tell you how soon the next procedure should happen ^[1].
• Consider a second opinion: If the recommendation is unclear or you are uncomfortable with the plan, it is highly reasonable to seek a second opinion from a dedicated breast specialist. You will need to bring your actual images, reports, and pathology slides to the new center.